2 models fit TransAct Technologies Incorporated Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a cyclical company: EV/EBITDA comparison and Discounted cash flow.
ACCE opinionTransAct Technologies Incorporated Common Stock (TACT)
Fair value (2 models)
$2.99
ACCE price target
$4.51
Rating
Overvalued
Horizon
12 months
Fair value published on 14 Oct 2026, 00:00 CEST; previously $3.06 since 6 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 17:04 CEST.
Price used: $5.27 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
76.0% above
-43.2% to fair value
ACCE score
55
out of 100
Analysts
100% buy
1 covering
1-year return
+13.3%
Dividend yield
0.00%
TransAct Technologies Incorporated Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
TransAct Technologies makes thermal receipt and label printers, point-of-sale and kiosk printing hardware, and the software that runs them, mostly sold into retail, hospitality and gaming. Its edge is installed-base stickiness: printers in restaurants, casinos and retail chains get replaced on a service cycle and carry consumables and support revenue, which keeps gross margin near 49.6%. Revenue growth is essentially flat at 1.1%, and operating margin sits at -0.4%, so there is no visible operating leverage yet. The stock trades at a forward P/E of 47.4 on a $47M market cap, which means the market is pricing a margin recovery that the trailing numbers do not yet show. With a score of 50/100 and no index membership, this is a small, illiquid name where the case rests on whether gross margin converts into operating profit, and that is worth checking in the next quarterly filings before anything else.